Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrated transcriptomic and in silico drug screening identifies potential stroma-targeting therapeutics in pancreatic cancer

ABSTRACT: Integrated transcriptomic and in silico drug screening identifies potential stroma-targeting therapeutics in pancreatic cancer

PROVIDER: PRJNA805246 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Integrated transcriptomic and in silico drug screening identifies potential stroma-targeting therapeutics in pancreatic cancer

Project description:This study identifies a gene panel that can distinguish two stromal subgroups of resected pancreatic cancers which have different microenvironment features and prognosis, and can be targeted by different therapeutic approaches. In-silico and in-vitro analysis indicates that our proposed signature could be further investigated as a predictor of response of immunomodulatory agents, including anti CD40 therapeutics

2025-02-10 | GSE196524 | GEO

Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

Project description:Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics

| PRJNA595156 | ENA

A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

Project description:A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology

| PRJNA996627 | ENA

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA104]

Project description:Integration of in silico and in vitro approaches to design and conduct transcriptomic drug screening in patient-derived neural cells, in order to survey novel pathologies and points of intervention in schizophrenia.

2018-10-31 | GSE119278 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA103]

2018-10-31 | GSE119277 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA106]

2018-10-31 | GSE119280 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA201]

2018-10-31 | GSE119283 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA105]

2018-10-31 | GSE119279 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA101]

2018-10-31 | GSE119275 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA202]